Recent IPR and District Court Litigation in the Life Sciences

Inventions in the life sciences are often the culmination of significant research and development efforts. To protect the value of these endeavors, it is critical to obtain patent claims capable of surviving patent eligibility, novelty, and Section 112 challenges. Join Finnegan attorneys Matthew Hlinka, Justin Hasford and Emmanuel Onochie as they explore recent developments in district court litigations and IPR proceedings in the life sciences. During this interactive webinar, you will be apprised of developments which can substantially impact patent protection for innovations in these areas. 

Topics will include:

• The application of Alice to biotech patents 
• The consequences of failing to comply with the duty of candor and fair dealing
• Recent decisions from U.S. District Courts and the Patent Trial and Appeal Board (PTAB)

Moderator:
Emmanuel Onochie

Speakers:
Justin Hasford
Matthew Hlinka